Printer friendly version Share

News Release

Muscle, skin and gastrointestinal problems cause a quarter of patients with heart disease and strokes to stop treatment in HPS2-THRIVE trial

25 February 2013 European Society of Cardiology (ESC)

Please login or register to view articles older than 3 months

Science Daily New Norwegian logo expertsvar 2015 eNEWS6 FNSF ad Cambridge blue millet Elhuyar with Basque